Sign in

NCT07786376Not yet recruiting

AI in Histipathological Diagnosis of Bcc

Evaluation of Artificial Intelligence Algorithms Performance in the Histopathological Diagnosis of Basal Cell Carcinoma

Source: ClinicalTrials.gov · Last updated 26 Aug 2026

Brief summary (registry, in English)

The goal of this study is to evaluate the diagnostic performance of an Artificial Intelligence (AI) algorithm in the histopathological diagnosis of bcc compared to certified dermatopathologists

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
50 (estimated)
First submitted
20 Aug 2026
Start date
1 Oct 2026
Primary completion date
1 Oct 2027
Lead sponsor
Al-Azhar University
NCT number
NCT07786376

What you commit to

  • Study type: Observational
  • Planned participants: 50
  • From 1 Oct 2026 to the primary completion date, 1 Oct 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Slides with poor staining quality or significant artifacts interfering with histopathological interpretation.
  • Slides that were damaged, faded, or inadequately preserved.
  • Cases with uncertain or inconclusive original diagnoses.
  • Slides that could not be successfully digitized due to technical limitations ex very short or too long slides.

Who the study is looking for

  • Histopathological slides diagnosed as BCC.
  • Slides with adequate staining and preservation allowing clear visualization of dermatopathological features.

Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Al hussein universty hospital
Coordinator of this site? Confirm its status
CairoEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.